Clinical Trial Update: The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Hemopatch® effectiveness in reducing post-surgical serous drainage in breast cancer patients undergoing axillary lymphadenectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hemopatch

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Hemopatch, Breast Cancer | Phase 4 | Status: UNKNOWN